Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

NCT00105040 ·Status: COMPLETED ·Phase: PHASE2

A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

NCT00367432 ·Status: COMPLETED ·Phase: PHASE3

Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.

NCT00150813 ·Status: COMPLETED ·Phase: PHASE3

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

NCT00160654 ·Status: COMPLETED ·Phase: PHASE4

A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy

NCT00361010 ·Status: COMPLETED ·Phase: NA

Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

NCT00544050 ·Status: COMPLETED ·Phase: PHASE2

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

NCT00150748 ·Status: COMPLETED ·Phase: PHASE3

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

NCT00490035 ·Status: COMPLETED ·Phase: PHASE3

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

NCT00152503 ·Status: COMPLETED ·Phase: PHASE2

Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution

NCT01210690 ·Status: COMPLETED

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

NCT00160615 ·Status: COMPLETED ·Phase: PHASE3

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

NCT01318408 ·Status: COMPLETED ·Phase: PHASE4

Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

NCT00600509 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

NCT01407523 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

NCT01398956 ·Status: COMPLETED ·Phase: PHASE3

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

NCT00152516 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

NCT00610454 ·Status: COMPLETED ·Phase: PHASE2

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

NCT00946751 ·Status: COMPLETED ·Phase: PHASE1

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

NCT00160628 ·Status: COMPLETED ·Phase: PHASE3

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

NCT00175890 ·Status: COMPLETED ·Phase: PHASE3

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

NCT00631150 ·Status: COMPLETED ·Phase: PHASE4

Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

NCT00150774 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

NCT00362141 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures)

NCT00376766 ·Status: TERMINATED ·Phase: PHASE3

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

NCT00630968 ·Status: COMPLETED ·Phase: PHASE4